174 related articles for article (PubMed ID: 26320103)
1. Genomic copy number analysis of Chernobyl papillary thyroid carcinoma in the Ukrainian-American Cohort.
Selmansberger M; Braselmann H; Hess J; Bogdanova T; Abend M; Tronko M; Brenner A; Zitzelsberger H; Unger K
Carcinogenesis; 2015 Nov; 36(11):1381-7. PubMed ID: 26320103
[TBL] [Abstract][Full Text] [Related]
2. Radiation induced thyroid cancer: fundamental and applied aspects.
Tronko M; Bogdanova T; Voskoboynyk L; Zurnadzhy L; Shpak V; Gulak L
Exp Oncol; 2010 Sep; 32(3):200-4. PubMed ID: 21403618
[TBL] [Abstract][Full Text] [Related]
3. Copy number and gene expression alterations in radiation-induced papillary thyroid carcinoma from chernobyl pediatric patients.
Stein L; Rothschild J; Luce J; Cowell JK; Thomas G; Bogdanova TI; Tronko MD; Hawthorn L
Thyroid; 2010 May; 20(5):475-87. PubMed ID: 19725780
[TBL] [Abstract][Full Text] [Related]
4. ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer.
Leeman-Neill RJ; Kelly LM; Liu P; Brenner AV; Little MP; Bogdanova TI; Evdokimova VN; Hatch M; Zurnadzy LY; Nikiforova MN; Yue NJ; Zhang M; Mabuchi K; Tronko MD; Nikiforov YE
Cancer; 2014 Mar; 120(6):799-807. PubMed ID: 24327398
[TBL] [Abstract][Full Text] [Related]
5. RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics.
Leeman-Neill RJ; Brenner AV; Little MP; Bogdanova TI; Hatch M; Zurnadzy LY; Mabuchi K; Tronko MD; Nikiforov YE
Cancer; 2013 May; 119(10):1792-9. PubMed ID: 23436219
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the Relationship Between Radiation Dose and Gene Mutations and Fusions in Post-Chernobyl Thyroid Cancer.
Efanov AA; Brenner AV; Bogdanova TI; Kelly LM; Liu P; Little MP; Wald AI; Hatch M; Zurnadzy LY; Nikiforova MN; Drozdovitch V; Leeman-Neill R; Mabuchi K; Tronko MD; Chanock SJ; Nikiforov YE
J Natl Cancer Inst; 2018 Apr; 110(4):371-378. PubMed ID: 29165687
[TBL] [Abstract][Full Text] [Related]
7. Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident.
Morton LM; Karyadi DM; Stewart C; Bogdanova TI; Dawson ET; Steinberg MK; Dai J; Hartley SW; Schonfeld SJ; Sampson JN; Maruvka YE; Kapoor V; Ramsden DA; Carvajal-Garcia J; Perou CM; Parker JS; Krznaric M; Yeager M; Boland JF; Hutchinson A; Hicks BD; Dagnall CL; Gastier-Foster JM; Bowen J; Lee O; Machiela MJ; Cahoon EK; Brenner AV; Mabuchi K; Drozdovitch V; Masiuk S; Chepurny M; Zurnadzhy LY; Hatch M; Berrington de Gonzalez A; Thomas GA; Tronko MD; Getz G; Chanock SJ
Science; 2021 May; 372(6543):. PubMed ID: 33888599
[TBL] [Abstract][Full Text] [Related]
8. CLIP2 as radiation biomarker in papillary thyroid carcinoma.
Selmansberger M; Feuchtinger A; Zurnadzhy L; Michna A; Kaiser JC; Abend M; Brenner A; Bogdanova T; Walch A; Unger K; Zitzelsberger H; Hess J
Oncogene; 2015 Jul; 34(30):3917-25. PubMed ID: 25284583
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent expression of CLIP2 in post-Chernobyl papillary thyroid carcinomas.
Selmansberger M; Kaiser JC; Hess J; Güthlin D; Likhtarev I; Shpak V; Tronko M; Brenner A; Abend M; Blettner M; Unger K; Jacob P; Zitzelsberger H
Carcinogenesis; 2015 Jul; 36(7):748-56. PubMed ID: 25957251
[TBL] [Abstract][Full Text] [Related]
10. Histopathological features of papillary thyroid carcinomas detected during four screening examinations of a Ukrainian-American cohort.
Bogdanova TI; Zurnadzhy LY; Nikiforov YE; Leeman-Neill RJ; Tronko MD; Chanock S; Mabuchi K; Likhtarov IA; Kovgan LM; Drozdovitch V; Little MP; Hatch M; Zablotska LB; Shpak VM; McConnell RJ; Brenner AV
Br J Cancer; 2015 Dec; 113(11):1556-64. PubMed ID: 26625214
[TBL] [Abstract][Full Text] [Related]
11. Gain of chromosome band 7q11 in papillary thyroid carcinomas of young patients is associated with exposure to low-dose irradiation.
Hess J; Thomas G; Braselmann H; Bauer V; Bogdanova T; Wienberg J; Zitzelsberger H; Unger K
Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9595-600. PubMed ID: 21606360
[TBL] [Abstract][Full Text] [Related]
12. BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas.
Lima J; Trovisco V; Soares P; Máximo V; Magalhães J; Salvatore G; Santoro M; Bogdanova T; Tronko M; Abrosimov A; Jeremiah S; Thomas G; Williams D; Sobrinho-Simões M
J Clin Endocrinol Metab; 2004 Sep; 89(9):4267-71. PubMed ID: 15356020
[TBL] [Abstract][Full Text] [Related]
13. Comparison of transcriptomic signature of post-Chernobyl and postradiotherapy thyroid tumors.
Ory C; Ugolin N; Hofman P; Schlumberger M; Likhtarev IA; Chevillard S
Thyroid; 2013 Nov; 23(11):1390-400. PubMed ID: 23521174
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident.
Fugazzola L; Pilotti S; Pinchera A; Vorontsova TV; Mondellini P; Bongarzone I; Greco A; Astakhova L; Butti MG; Demidchik EP
Cancer Res; 1995 Dec; 55(23):5617-20. PubMed ID: 7585643
[TBL] [Abstract][Full Text] [Related]
15. Gene signature of the post-Chernobyl papillary thyroid cancer.
Handkiewicz-Junak D; Swierniak M; Rusinek D; Oczko-Wojciechowska M; Dom G; Maenhaut C; Unger K; Detours V; Bogdanova T; Thomas G; Likhtarov I; Jaksik R; Kowalska M; Chmielik E; Jarzab M; Swierniak A; Jarzab B
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1267-77. PubMed ID: 26810418
[TBL] [Abstract][Full Text] [Related]
16. Contribution of ATM and FOXE1 (TTF2) to risk of papillary thyroid carcinoma in Belarusian children exposed to radiation.
Damiola F; Byrnes G; Moissonnier M; Pertesi M; Deltour I; Fillon A; Le Calvez-Kelm F; Tenet V; McKay-Chopin S; McKay JD; Malakhova I; Masyakin V; Cardis E; Lesueur F; Kesminiene A
Int J Cancer; 2014 Apr; 134(7):1659-68. PubMed ID: 24105688
[TBL] [Abstract][Full Text] [Related]
17. Molecular Profiling of Papillary Thyroid Carcinoma in Korea with a High Prevalence of BRAF
Lee SE; Hwang TS; Choi YL; Kim WY; Han HS; Lim SD; Kim WS; Yoo YB; Kim SK
Thyroid; 2017 Jun; 27(6):802-810. PubMed ID: 28293988
[TBL] [Abstract][Full Text] [Related]
18. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma.
Costa AM; Herrero A; Fresno MF; Heymann J; Alvarez JA; Cameselle-Teijeiro J; García-Rostán G
Clin Endocrinol (Oxf); 2008 Apr; 68(4):618-34. PubMed ID: 18070147
[TBL] [Abstract][Full Text] [Related]
19. The presence of BRAF point mutation in adult papillary thyroid carcinomas from atomic bomb survivors correlates with radiation dose.
Takahashi K; Eguchi H; Arihiro K; Ito R; Koyama K; Soda M; Cologne J; Hayashi Y; Nakata Y; Nakachi K; Hamatani K
Mol Carcinog; 2007 Mar; 46(3):242-8. PubMed ID: 17186541
[TBL] [Abstract][Full Text] [Related]
20. Frequency of BRAF T1796A mutation in papillary thyroid carcinoma relates to age of patient at diagnosis and not to radiation exposure.
Powell N; Jeremiah S; Morishita M; Dudley E; Bethel J; Bogdanova T; Tronko M; Thomas G
J Pathol; 2005 Apr; 205(5):558-64. PubMed ID: 15714593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
